American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Items 401–500 of 1,001
Kosiborod, M., & DEEDWANIA, P. C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300614 · Cited by 24
Giakoumidakis, K., Nenekidis, I., & Brokalaki, H. (2012) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515111430887 · Cited by 23
Pretty, C. G. (2012) · UC Research Repository (University of Canterbury) · doi:10.26021/2015 · Cited by 23
Abegaz, T. M., Ahmed, M. B., Sherbeny, F., Diaby, V., Chi, H., & Ali, A. A. (2023) · Healthcare · doi:10.3390/healthcare11081138 · Cited by 22
“DM causes several complications in different vital organs of the body, including the heart, brain, kidney, and eye [4].”
BackgroundOlsen, M. T., Klarskov, C. K., Pedersen‐Bjergaard, U., Hansen, K. B., & Kristensen, P. L. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01595-4 · Cited by 22
Krutkyte, G., GOERG, A. M. C., Grob, C. A., Piazza, C. D., Rolfes, E., Gloor, B., Wenning, A. S., Beldi, G., Kollmar, O., Hovorka, R., et al. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006549 · Cited by 22
“41 Insulin delivery, if performed safely, not only corrects hyperglycemia but also lowers in fl ammation and promotes an anabolic state needed for postoperative recovery, providing multifaceted treatment advantages.”
Glycemic control in cardiac surgery: Rationale and current evidence
Girish, G., Agarwal, S., Satsangi, D. K., Tempe, D. K., Dutta, N., & Pratap, H. (2014) · Annals of Cardiac Anaesthesia · doi:10.4103/0971-9784.135873 · Cited by 22
Vaidya, A., Hurwitz, S., Yialamas, M. A., Min, L., & Garg, R. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0258 · Cited by 22
A Comparison of Inpatient Glucose Management Guidelines: Implications for Patient Safety and Quality
Mathioudakis, N. N., & Golden, S. H. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0583-8 · Cited by 22
Diabetes or endocrinopathy admitted in the COVID‐19 ward
Clotman, K., & Twickler, M. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13262 · Cited by 22
Naderi-Behdani, F., Heydari, F., Ala, S., Moradi, S., Abediankenari, S., Asgarirad, H., & Khodabakhsh, E. (2022) · PubMed Central · doi:10.22088/cjim.13.1.51 · Cited by 22
Postoperative Glycemic Control in Cardiac Surgery Patients
Breithaupt, T. (2010) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2010.11928586 · Cited by 22
Controle de hiperglicemia intra-hospitalar em pacientes críticos e não-críticos
Gomes, P. M., Foss, M. C., & Foss‐Freitas, M. C. (2014) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v47i2p194-200 · Cited by 22
Use Of Incretin-Based Therapy in Hospitalized Patients with Hyperglycemia
Umpierrez, G. E., & Schwartz, S. S. (2014) · Endocrine Practice · doi:10.4158/ep13471.ra · Cited by 22
Self-citationTamler, R., Green, D. E., Skamagas, M., Breen, T. L., Lu, K., Looker, H. C., Babyatsky, M. W., & LeRoith, D. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00189.x · Cited by 22
Hyperglycemia in Nondiabetic Patients Presenting With Acute Myocardial Infarction
Shah, B., Amoroso, N. S., & Sedlis, S. P. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31822fb423 · Cited by 22
Inpatient dysglycemia and clinical outcomes: Association or causation?
Umpierrez, G. E., & Kosiborod, M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.008 · Cited by 22
“patients (Moghissi et al., 2009; Umpierrez et al., 2012), real-world clinical data suggest marked variability in treatment rates across”
BackgroundSelf-citationGalindo, R. J., Davis, G. M., Fayfman, M., Reyes-Umpierrez, D., Alfa, D., Peng, L., Tamler, R., Pasquel, F. J., & Umpierrez, G. E. (2017) · Endocrine Practice · doi:10.4158/ep171804.or · Cited by 21
“Similarly, both institutions have protocols for the management of hypoglycemia, starting therapy for BG < 70 mg/dl at that time (6, 7).”
BackgroundSelf-citationSinha Gregory, N., Seley, J. J., Gerber, L. M., Tang, C., & Brillon, D. (2016) · Hospital Practice · doi:10.1080/21548331.2016.1250603 · Cited by 21
“…consensus conference hosted by the American Association of Clinical Endocrinologists and the American Diabetes Association identified institutional insulin management protocols and standardized insulin order sets as essential interventions to address key barriers to inpatient glycemic control [18].”
BackgroundWilliams, J. B., Peterson, E. D., Albrecht, Á., Li, S., Hirji, S. A., Ferguson, T. B., Smith, P. K., & Lópes, R. D. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.09.013 · Cited by 21
“Acute diseases can cause hyperglycemia, and it remains unclear whether glucose variation is a marker of an underlying health condition, or simply a mediator of complications [5].”
You, H., Hou, X., Zhang, H., Li, X., Feng, X., Qian, X., Shi, N., Guo, R., Wang, X., Sun, H., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00984-4 · Cited by 21
Association between Preoperative Glucose Dysregulation and Delirium after Non-Cardiac Surgery
Oh, A. R., Lee, D. Y., Lee, S. H., Lee, J.-H., Yang, K., Choi, B., & Park, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040932 · Cited by 21
“Hyperglycemia was defined as at least one fasting blood glucose level >140 mg/dL or random glucose >180 mg/dL within 24 h before surgical incision according to the American Diabetes Association and American Association of Clinical Endocrinology guidelines [10].”
MethodWang, Y., Lu, J., Wang, M., Ni, J., Yu, J., Wang, S., Wu, L., Lu, W., Zhu, W., Guo, J., et al. (2024) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2024.101067 · Cited by 21
“36 Despite this, the use of rtCGM still achieved improvements in glucose outcomes compared to the POC standard of care.”
Comparison of Insulin Infusion Protocols Targeting 110–140 mg/dL in Patients After Cardiac Surgery
Magaji, V., Nayak, S., Donihi, A. C., Willard, L. A., Jampana, S., Nivedita, P., Eder, R., Johnston, J., & Korytkowski, M. T. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0114 · Cited by 21
Self-citationLi, Q., Chitnis, A. S., Hammer, M., & Langer, J. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0084-9 · Cited by 21
“Severe hypoglycemic events were identified by both ICD-9-CM codes [17] and recorded fasting plasma glucose level of less than or equal to 40 mg/dL [18].”
BackgroundGriffing, K. L. (2016) · Clinical Diabetes · doi:10.2337/cd15-0055 · Cited by 21
“A checklist of precipitating factors that lead to hypoglycemia, derived from literature (1,6,16,18) and from experience in inpatient diabetes management, was used to document the most likely primary and contributory factors for the occurrence of hypoglycemia.”
MethodHessel, E. A., & Levy, J. H. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181fbb386 · Cited by 21
“However, 5 subsequent RCTs failed to replicate these findings and the largest one actually demonstrated harm.17 This led to a revision of the consensus statement from the American Association of Clinical Endocrinologists and American Diabetes Association.18 Another example of a well-intended guideline that had to be m…”
MethodCushing′s surgery: Role of the anesthesiologist
Domi, R. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.86975 · Cited by 21
“67 to 10 mmol/l]) during the perioperative period.[38] The guidelines of American Association of Clinical Endocrinologists and the ADA have recommended target values to 140–180 mg/dl for ICU and 100–180 mg/ dl as a target for the diabetic patients in medical and surgical wards.”
BackgroundA Prediction Model for Adverse Outcome in Hospitalized Patients With Diabetes
Nirantharakumar, K., Hemming, K., Narendran, P., Marshall, T. P., & Coleman, J. J. (2013) · Diabetes Care · doi:10.2337/dc13-0452 · Cited by 21
Mazaherioun, M., Djalali, M., Koohdani, F., Javanbakht, M. H., Zarei, M., Beigy, M., Ansari, S., Rezvan, N., & Saedisomeolia, A. (2017) · Medical Principles and Practice · doi:10.1159/000484089 · Cited by 20
Patient Self-Management of Diabetes Care in the Inpatient Setting: Con
Shah, A. D., & Rushakoff, R. J. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815586581 · Cited by 20
A randomized trial of continuous glucose monitoring to improve post‐transplant glycemic control
Jandovitz, N., George, S. J., Abate, M. T., Kressel, A. M., Bolognese, A. C., Lau, L., Nair, V. V., & Grodstein, E. I. (2023) · Clinical Transplantation · doi:10.1111/ctr.15139 · Cited by 20
Huri, H. Z., Makmor‐Bakry, M., Hashim, R., Mustafa, N., & Ngah, W. Z. W. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9682-7 · Cited by 20
Yoon, J. A., Kim, D. Y., Sohn, M. K., Lee, J., Lee, S. ‐., Lee, Y. ‐., Han, E. Y., Joo, M. C., Oh, G. ‐., Han, J., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.13101 · Cited by 20
Predictors of discharge destination after complex abdominal wall reconstruction
Ayyala, H. S., Weisberger, J. S., Le, T.-M. T., Chow, A. L., & Lee, E. S. (2019) · Hernia · doi:10.1007/s10029-019-02054-z · Cited by 20
Daily Evolution of Insulin Sensitivity Variability with Respect to Diagnosis in the Critically Ill
Ferenci, T., Benyó, B. I., Kovács, L., Fisk, L., Shaw, G. M., & Chase, J. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057119 · Cited by 20
A Literature Review of Intensive Insulin Therapy and Mortality in Critically Ill Patients
Chen, L. (2010) · Clinical Nurse Specialist · doi:10.1097/nur.0b013e3181cf55af · Cited by 20
“1 mmol/L) were not recommended for critically ill patients in the ICU setting in the 2009 American Association of Clinical Endocrinologists/American Diabetes Association Consensus Statement.(38,39) Also, based on the NICE-SUGAR trial data, the Institute for Healthcare Improvement advocated for a glucose target less th…”
BackgroundInfluentialYang, M., Jaeger, M. T., Baxter, M., VanDenKerkhof, E. G., & van Vlymen, J. (2016) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-016-0742-7 · Cited by 20
“1 mMol L.(3,5,6,8-10,12,14,15,20,23-25) As we could not guarantee that the CBG measurements were always premeal, our definition of hyperglycemia also took into account clinical practice guidelines that recommend a pre-meal glucose target\7.”
BackgroundAgus, M. S. D., Hirshberg, E. L., Srinivasan, V., Faustino, E. V. S., Luckett, P. M., Curley, M. A. Q., Alexander, J. L., Asaro, L. A., Coughlin-Wells, K., Duva, D., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.12.023 · Cited by 20
“The higher target range was chosen based upon a survey of pediatric intensivists [9] and consensus recommendations reported in statements from multiple critical care and endocrine societies (150–180 [46]; 140–180 [47]; 140–200 [48]).”
BackgroundPerioperative management of the patient with diabetes requiring emergency surgery
Levy, N., Penfold, N. W., & Dhatariya, K. (2016) · BJA Education · doi:10.1093/bjaed/mkw056 · Cited by 20
A Systematic Approach for the Prevention and Reduction of Hypoglycemia in Hospitalized Patients
Cruz, P., Blackburn, M. C., & Tobin, G. S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0934-8 · Cited by 20
Diabetes management before, during, and after bariatric and metabolic surgery
Kheniser, K. G., & Kashyap, S. R. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.06.006 · Cited by 20
Carvalho, R. C., Nishi, F. A., Ribeiro, T. B., França, G. G., & Aguiar, P. M. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200130093523 · Cited by 20
Multi-Zone-MPC: Clinical Inspired Control Algorithm for the Artificial Pancreas
Grosman, B., Dassau, E., Zisser, H., Jovanovic, L. G., & Doyle, F. J. (2011) · IFAC Proceedings Volumes · doi:10.3182/20110828-6-it-1002.02215 · Cited by 20
“Guided by medical practice (Nathan et al., 2008 and Moghissi et al., 2009), the blood glucose concentration can be divided into four zones: zone 1, hyperglycemia, BG > 180 mg/dL; zone 2, near normal glycemia, 140 < BG <180 mg/dL; zone 3, normoglycemia, 80 < BG < 140 mg/dL, and zone 4, danger of…”
MethodWu, E. Q., Zhou, S., Yu, A., Lü, M., Sharma, H., Gill, J., & Graf, T. R. (2012) · Endocrine Practice · doi:10.4158/ep11314.or · Cited by 20
Panayi, A. C., Knoedler, S. A., Alfertshofer, M. G., Matar, D. Y., Friedrich, S., Rühl, J., Haug, V., Gazyakan, E., Bigdeli, A. K., Kneser, U., et al. (2025) · Annals of Surgery · doi:10.1097/sla.0000000000006664 · Cited by 20
[Management of hyperglycemia in the hospitalized patient].
Pasquel, F. J., & Umpierrez, G. E. (2010) · PubMed · Cited by 19
Self-citationPerioperative care in cardiac surgery
Pokhrel, S., Gregory, A. J., & Mellor, A. J. (2021) · BJA Education · doi:10.1016/j.bjae.2021.05.008 · Cited by 19
Hyperglycemia in the Perioperative Period
Shuford, R., & Miller-Ocuin, J. L. (2023) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0043-1761153 · Cited by 19
An Update on the Interdisciplinary Dental Care Approach for Geriatric Diabetic Patients
Surlari, Z., Ciurcanu, O. E., Budală, D. G., Butnaru, O., & Luchian, I. A. (2023) · Geriatrics · doi:10.3390/geriatrics8060114 · Cited by 20
“…glucose concentration targets of fewer than 7.8 mmol/L (140 mg/dL) and random blood glucose concentration objectives of less than 10.0 mmol/L (180 mg/dL) are advised for non-critically sick individuals with hyperglycemia in the Endocrine Society guidelines and the ADA-AACE consensus statement [84].”
BackgroundInfluentialda Costa, L. F., Sampaio, T. L., de Moura, L., Rosa, R. D. S., & Iser, B. P. M. (2023) · Epidemiologia e Serviços de Saúde · doi:10.1590/s2237-96222023000400006.pt · Cited by 19
Ghosh, J., Choudhury, S. R., Singh, K., & Koner, S. (2024) · International Journal of Advancement in Life Sciences Research · doi:10.31632/ijalsr.2024.v07i02.004 · Cited by 19
Yazawa, Y., Ohira, T., Itabashi, R., Uchida, K., Sakai, N., Yamagami, H., Morimoto, T., Yoshimura, S., & on behalf of RESCUE-Japan Registry 2 Investigators (2020) · Cerebrovascular Diseases · doi:10.1159/000511679 · Cited by 19
Tuna, M., Manuel, D. G., Bennett, C. L., Lawrence, N., van Walraven, C., Keely, E., Malcolm, J., Reid, R. D., & Forster, A. J. (2014) · Journal of Hospital Medicine · doi:10.1002/jhm.2181 · Cited by 19
“Previous studies have shown that diabetes and stress hyperglycemia among hospitalized patients are important markers for poor clinical outcomes and inhospital mortality.(1,2,4) This study indicates that hospitalized patients with extreme hyperglycemia (peak serum glucose >200 mg/dL) were at a high risk of death for at…”
BackgroundHow to Best Manage Glycemia and Non-Glycemia During the Time of Acute Myocardial Infarction
Hirsch, I. B., & O’Brien, K. D. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0095 · Cited by 19
Self-citationBasal-Bolus Insulin Protocols Enter the Computer Age
Wei, N., & Wexler, D. J. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0240-9 · Cited by 19
Optimal Perioperative Medical Management of the Vascular Surgery Patient
Singh, S., Maldonado, Y., & Taylor, M. A. (2014) · Anesthesiology Clinics · doi:10.1016/j.anclin.2014.05.007 · Cited by 19
Documento de consenso sobre el tratamiento al alta hospitalaria del paciente con hiperglucemia
Pérez, A., Gómez‐Huelgas, R., Guisasola, F. Á., Alegría, J. G., Bravo, J. J. M., & Torre, E. L. M. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.02.019 · Cited by 20
Incretin treatment and atherosclerotic plaque stability: Role of adiponectin/APPL1 signaling pathway
Barbieri, M., Marfella, R., Esposito, A., Rizzo, M. R., Angellotti, E., Mauro, C., Siniscalchi, M., Chirico, F., Caiazzo, P., Furbatto, F., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.001 · Cited by 19
National guidance contributes to the high incidence of inpatient hypoglycaemia
Levy, N., & Hall, G. M. (2018) · Diabetic Medicine · doi:10.1111/dme.13795 · Cited by 19
Year in review 2009: Critical Care - metabolism
Huberlant, V., & Preiser, J. (2010) · Critical Care · doi:10.1186/cc9256 · Cited by 19
Perioperative management of adult diabetic patients. Postoperative period
Cheisson, G., Jacqueminet, S., Cosson, E., Ichaï, C., Leguerrier, A.-M., Catargi, B., Ouattara, A., Tauveron, I., Valensi, P. E., & Benhamou, D. (2018) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2018.02.023 · Cited by 19
Intraoperative Hyperglycemia and Postoperative Bacteremia in the Pediatric Cardiac Surgery Patient
O’Brien, J. E., Marshall, J. A., Tarrants, M. L., Stroup, R. E., & Lofland, G. K. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.10.054 · Cited by 19
Poljakova, I., Elšíková, E., Chlup, R., Kalabus, S., Hasala, P., & Zapletalová, J. (2013) · Biomedical Papers · doi:10.5507/bp.2013.049 · Cited by 19
“Preoperative glycated haemoglobin HbA1c (IFCC) above 7% (ref.(13,43-45)) or marked preoperative glycaemic variability (The interpretation of HbA1c should take into account recent blood transfusions, haemolytic processes, haemoglobinopathies etc.”
BackgroundGlycemic Control in the Burn Intensive Care Unit: Focus on the Role of Anemia in Glucose Measurement
Mann, E. A., Mora, A. G., Pidcoke, H. F., Wolf, S. E., & Wade, C. E. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300612 · Cited by 19
Ables, A. Z., Bouknight, P., Bendyk, H. A., Beagle, R., Alsip, R., & Williams, J. J. (2016) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000023 · Cited by 19
Steroid-induced hyperglycaemia in hospitalised patients: does it matter?
Cheung, N. W. (2016) · Diabetologia · doi:10.1007/s00125-016-4116-z · Cited by 19
“8 mmol/l preprandially and <10 mmol/l at other times (as recommended by the American Association of Clinical Endocrinologist and American Diabetes Association Guidelines [8]) are often not achieved given the patient’s changing clinical status and steroid dosage, and the limited opportunities for insulin dose titration…”
BackgroundInfluentialEvaluation of the timing and coordination of prandial insulin administration in the hospital
Alwan, D., Chipps, E., Yen, P.-Y., & Dungan, K. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.021 · Cited by 18
Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journey
Irace, C., Coluzzi, S., Cianni, G. D., Forte, E., Landi, F., Rizzo, M. R., Sesti, G., Succurro, E., & Consoli, A. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.06.021 · Cited by 18
Xia, W., Li, C., Kuang, M., Wu, Y., Xu, L., & Hu, H. W. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03278-z · Cited by 18
“Acute glycemia was any blood or capillary glucose > 198 mg/dl during ICU stay [17].”
Backgroundda Costa, L. F., Sampaio, T. L., de Moura, L., Rosa, R. D. S., & Iser, B. P. M. (2023) · Epidemiologia e Serviços de Saúde · doi:10.1590/s2237-96222023000400006.en · Cited by 18
“It is known that DM length of stay tends to be longer 25 and that the following factors are associated with longer stays: being of the male sex, age (60 or over), low level of education and previous diabetes decompensation, with a higher risk of readmission within 30 days.”
BackgroundLee, P. H., Franks, A. S., Barlow, P. B., & Farland, M. Z. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0168 · Cited by 18
Gerards, M. C., Tervaert, E. C. C., Hoekstra, J. B. L., Vriesendorp, T. M., & Gerdes, V. E. A. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.040 · Cited by 18
Mukherjee, J. J., Chatterjee, P., Saikia, M., Muruganathan, A., & Das, A. K. (2014) · PubMed · Cited by 18
Helmle, K. E., Chacko, S., Chan, T., Drake, A., Edwards, A. L., Moore, G., Philp, L. C., Popeski, N., Roedler, R. L., Rogers, E., et al. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.12.010 · Cited by 18
Offodile, A. C., Chou, H., Lin, J. A., Loh, C. Y. Y., Chang, K., Aycart, M. A., & Kao, H. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.02.009 · Cited by 18
Addressing Inpatient Glycaemic Control with an Inpatient Glucometry Alert System
Seheult, J. N., Pazderska, A., Gaffney, P. R., Fogarty, J. P., Sherlock, M., Gibney, J., & Boran, G. P. (2015) · International Journal of Endocrinology · doi:10.1155/2015/807310 · Cited by 18
Incretins and the intensivist: what are they and what does an intensivist need to know about them?
Plummer, M. P., Chapman, M. J., Horowitz, M., & Deane, A. M. (2014) · Critical Care · doi:10.1186/cc13737 · Cited by 18
Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control
Ullal, J., & Aloi, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1254-y · Cited by 18
Wintergerst, K. A., Foster, M. B., Sullivan, J. E., & Woods, C. R. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600102 · Cited by 18
Inpatient Management of Adults and Children with Type 1 Diabetes
Tridgell, D. M., Tridgell, A. H., & Hirsch, I. B. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.014 · Cited by 18
Self-citationSiegelaar, S. E., Hoekstra, J. B. L., & DeVries, J. H. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.03.004 · Cited by 18
Validity of Meta-analysis in Diabetes: Meta-analysis Is an Indispensable Tool in Evidence Synthesis
Golden, S. H., & Bass, E. B. (2013) · Diabetes Care · doi:10.2337/dc13-1196 · Cited by 18
Evaluating perioperative glycemic control of non-cardiac surgical patients with diabetes
Todd, L. A., & Vigersky, R. A. (2020) · Military Medicine · doi:10.1093/milmed/usaa467 · Cited by 17
Emgin, Ö., Yavuz, M., Şahin, A., Güneş, M., Eser, M., Yavuz, T., Kökalan, D., Ergün, B., Rollas, K., & Çakırgöz, M. Y. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226939 · Cited by 17
“Patients who had less than 6 BGL measures per 24 h were excluded (Figure 1—flowchart) [13].”
InfluentialReview Article – Diabetes Technology in the Hospital: An Update
Visser, M. M., Vangoitsenhoven, R., Gillard, P., & Mathieu, C. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01545-3 · Cited by 17
Dejen, E. T., Workie, M. M., Zeleke, T. G., Admass, B. A., Melesse, D. Y., & Belayneh, T. (2024) · BMC Anesthesiology · doi:10.1186/s12871-024-02592-9 · Cited by 17
“According to the American College of Endocrinology and the American Association of Clinical Endocrinolo-gists, hyperglycemia is defined as any blood sugar level exceeding 140 mg/dl ( > 7.8 mmol/l) [1].”
BackgroundMethodInfluentialAnalysis of a Guideline-Derived Resident Educational Program on Inpatient Glycemic Control
Horton, W. B., Weeks, A. Q., Rhinewalt, J. M., Ballard, R. D., & Asher, F. H. (2015) · Southern Medical Journal · doi:10.14423/smj.0000000000000348 · Cited by 17
Rajpal, A., Kassem, L. S., & Aron, D. C. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1927708 · Cited by 17
“Poor glycemic control during inpatient care is associated with increased morbidity, mortality, and length of stay [18,19].”
BackgroundZhang, Z., Zhao, Y., Liu, Y., Wang, X., Xu, H., Fang, Y., Zhang, A., Lenahan, C., Luo, Y., & Chen, S. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13826 · Cited by 17
Analytic Review: Glucose Controversies in the ICU
Honiden, S., & Inzucchi, S. E. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610387892 · Cited by 17
Self-citationPasquel, F. J., Smiley, D. D., Spiegelman, R., Lin, E., Peng, L., & Umpierrez, G. E. (2011) · Hospital Practice · doi:10.3810/hp.2011.04.397 · Cited by 17
Self-citationJeon, C. Y., Furuya, E. Y., Smaldone, A. M., & Larson, E. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.007 · Cited by 17
“patients or critically ill patients regardless of diabetes status vary in recommended target glucose levels, with minimum thresholds ranging from 80 mg/dL to 140 mg/dL and maximum thresholds ranging from 110 mg/dL to 200 mg/dL (Lazar et al., 2009; Moghissi et al., 2009; Qaseem, Humphrey, Chou, Snow, & Shekelle, 2011;…”
BackgroundMethodPreoperative “NPO” as an opportunity for diabetes screening
Sheehy, A. M., Benca, J., Glinberg, S. L., Li, Z., Nautiyal, A., Anderson, P. A., Squire, M. W., & Coursin, D. B. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.1958 · Cited by 17
Controversies in the peripartum management of diabetes
Modi, A., Levy, N., & Hall, G. M. (2016) · Anaesthesia · doi:10.1111/anae.13487 · Cited by 17
Kefale, A. T. (2016) · Journal of Health, Medicine and Nursing · Cited by 17
Maynard, G. A., Holdych, J., Kendall, H. E., Harrison, K., Montgomery, P. A., & Kulasa, K. M. (2017) · Endocrine Practice · doi:10.4158/ep161569.or · Cited by 17
Impact of an inpatient multidisciplinary glucose control management program
Momesso, D., Filho, R. C., Costa, J. L. F., Saddy, F., de Mesquita, A. F., Calomeni, M., Silva, C. D. S., Farret, J., Vasques, M. L., Santos, A. G., et al. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000071 · Cited by 17
“Optimal glycemic control also includes the prevention of hypoglycemia (1-6,24-26).”
BackgroundInfluentialEffect of Treatment and Nutrition on Glycemic Variability in Critically Ill Patients
Kapłan, C., Kalemba, A., Krok, M., & Krzych, Ł. J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084717 · Cited by 17
“Hence, the current consensus is that glycemia should be controlled within the range of 140–180 mg/dL [12] and the signal to initiate insulin therapy is its value >200 mg/dL found twice.”
BackgroundManagement of comorbidities in ambulatory anesthesia: a review
Shelley, K. H., & Dabu-Bondoc, S. M. (2015) · Ambulatory Anesthesia · doi:10.2147/aa.s64924 · Cited by 17
“The American Association of Clinical Endocrinolo-gists with the American Diabetes Association Consensus Statement 87 is nearly in conformity with the NHS guidelines regarding the ideal inhospital glucose range for noncritically ill DM patients: 6–10 mmol/L (in the US, the lower limit is 5.6 mmol/L or 100 mg/dL).”
Influential
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.